Finally, in cases of mastocytosis that are typically associated with unfavorable outcomes (i.e. aggressive systemic mastocytosis and mast cell leukemia), the mast cells exhibit aberrant expression of CD25 and usually do not express CD2. Here, CD2 is linked to mast cell leukemia.